Recent news on Levonorgestrel Ethinyl Estradiol

FDA Approves Continuous-Use Contraceptive  -  May 24, 2007
Facts and Comparisons,The FDA has approved Wyeth Laboratories’ Lybrel (levonorgestrel 90 mcg/ ethinyl estradiol 20 mcg), the first continuous-use oral drug product for prevention

Market Report -- In Play (WYE)  -  May 22, 2007
MSN MoneyWyeth announced FDA approves Lybrel, first low dose combination oral contraceptive offering women the opportunity to be period-free over time Co announced

FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral ...  -  Apr 12, 2007
Drug Newswire (press release),Inc.'s New Drug Application (NDA) for SEASONIQUE(TM) (levonorgestrel/ethinyl estradiol tablets 0.15 mg/0.03 mg and ethinyl estradiol tablets 0.01 mg)

Shire sues Colony and Actavis over Adderall XR infringement  -  Mar 23, 2007
Pharma Times (subscription),...technology developed by Barr's Duramed subsidiary, as well as a licence for Duramed's oral contraceptive Seasonique (levonorgestrel/ethinyl estradiol).

SHIRE PLC: Final Results  -  Feb 20, 2007
FinanzNachrichten.de,...markets in August 2006, together with a license in the same countries to Duramed's oral contraceptive, SEASONIQUE® (levonorgestrel/ethinyl estradiol).

Studies Examine Menopause Treatments, Oral Contraception To ...  -  Jan 2, 2007
Medical News Today (press release),..."Evaluation of a Continuous Regimen of Levonorgestrel/Ethinyl Estradiol: Phase 3 Study Results," Contraception : David Archer, a Wyeth consultant from the

Studies Examine Menopause Treatments, Oral Contraception to ...  -  Dec 22, 2006
Kaiser network.org,..."Evaluation of a Continuous Regimen of Levonorgestrel/Ethinyl Estradiol: Phase 3 Study Results," Contraception : David Archer, a Wyeth consultant from the

Shire plc: Excellent Third Quarter With Execution Plan on Track ...  Oct 27, 2006
...women's health products, as well as a license to Duramed's currently marketed oral contraceptive, SEASONIQUE® (levonorgestrel/ethinyl estradiol tablets 0.15 mg ... -Yahoo! News (press release) Shire plc: Excellent Third Quarter With Execution Plan on Track ...  Oct 27, 2006
...women's health products, as well as a license to Duramed's currently marketed oral contraceptive, SEASONIQUE(R) (levonorgestrel/ethinyl estradiol tablets 0.15 ... -PR Newswire (press release), Pill to end misery of PMS  Oct 24, 2006
The new pill, Lybrel (levonorgestrel / ethinyl estradiol), is designed to be taken every day and has been shown to reduce breast pain and nausea. ... -Daily Mail - UK, First-Time Generic Approvals: Seasonale, Imodium Advanced, and ...  Sep 22, 2006
...the trade name Jolessa. Levonorgestrel/ethinyl estradiol is indicated for contraceptive use in women. The extended-cycle regimen ... -Medscape (subscription)

Weekly Wrap-up - Pharma Sector: Genta's Genasense Gets Knockout ...  Sep 10, 2006
In May 2006, Barr received approval for its SEASONIQUE (levonorgestrel/ethinyl estradiol tablets 0.15 mg/0.03 mg and ethinyl estradiol tablets 0.01 mg) extended ... -Trading Markets

Shire plc: IFRS Information - First Half of 2006  Sep 18, 2006
...women's health products, as well as a license to Duramed's currently marketed oral contraceptive, Seasonique ( levonorgestrel/ethinyl estradiol tablets 0.15 mg ... -PR Newswire

Watson Pharmaceuticals Receives FDA Final Approval for Generic ...  Sep 8, 2006
...from the United States (US) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for levonorgestrel / ethinyl estradiol tablets USP ... -PipelineReview.com

Shire and Barr Settle All Pending Litigation Concerning ADDERALL ...  Aug 14, 2006
...women's health products, as well as a license to Duramed's currently marketed oral contraceptive, Seasonique (levonorgestrel/ethinyl estradiol tablets 0.15 mg ... -Finanzen.net

Barr & Shire Sign Three Agreements  Aug 15, 2006
...regulatory approval for and market in certain specified territories Duramed's recently approved SEASONIQUE (levonorgestrel/ethinyl estradiol tablets 0.15 mg ... -ag-IP-news Agency

Parties Agree to Settle Pending Patent Litigation Regarding ...  Aug 14, 2006
...regulatory approval for and market in certain specified territories Duramed's recently approved SEASONIQUE(TM) (levonorgestrel/ethinyl estradiol tablets 0.15 mg ... -Yahoo! News

Shire settles with Barr over Adderall XR  Aug 15, 2006
...by Barr's Duramed subsidiary, as well as a license for Duramed's already-marketed oral contraceptive Seasonique (levonorgestrel/ethinyl estradiol) in the five ... -Pharma Times (subscription)

Wyeth Reports Earnings Results for the 2006 Second Quarter and ...  Jul 20, 2006
The Company also expects approval of LYBREL(TM) (levonorgestrel/ethinyl estradiol), a novel continuous regimen oral contraceptive for which Wyeth received an ... -PR Newswire



Watson Pharma's Generic Seasonale Gets Tentative FDA Approval ...  May 9, 2006
...approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for levonorgestrel / ethinyl estradiol tablets USP, 0.15 ... - Trading Markets

New Findings From Two Studies on Lybrel Presented at ACOG  May 8, 2006
Abstract: Comparative Trial of Continuous-Use and 21-Day Cyclic Levonorgestrel/Ethinyl Estradiol Oral Contraceptives This scientific abstract reported on the ... - PR Newswire

Watson Pharmaceuticals Receives FDA Tentative Approval for Generic ...  May 9, 2006
...today from the United States (US) Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for levonorgestrel / ethinyl estradiol tablets USP ... - Yahoo! News

Watson 1Q profit drops 35 percent  May 9, 2006
...exchange. Levonorgestrel/ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets. ... - BusinessWeek

Watson nears OK on generic Seasonale  May 9, 2006
The company said the Food and Drug Administration has given its tentative clearance to its applications for levonorgestrel/ethinyl estradiol tablets 0.15 mg ... - United Press International

Wyeth Reports Earnings Results for the 2006 First Quarter  Apr 21, 2006
The Company expects approval of LYBREL(TM) (levonorgestrel/ethinyl estradiol), a new oral contraceptive with a unique dosing regimen, in the coming months and ... - MSN Money





Barr's Duramed Withdraws NDA for Lo SEASONALE(R) Extended-Cycle ...  Apr 6, 2006
...its subsidiary, Duramed Pharmaceuticals, Inc., has withdrawn its New Drug Application (NDA) for Lo SEASONALE® (levonorgestrel/ethinyl estradiol tablets 0.10 mg ... - Yahoo! News

Pipeline Insight: Anxiety Disorders - A decade of declining ...  Mar 28, 2006
III for GAD, and Schering AG/Berlex's YAZ (low dose drospirenone/ethinyl estradiol) and Wyeth's Librel (low dose levonorgestrel/ethinyl estradiol), both in ... - Pharmaceutical Business Review

Barr Confirms that Additional Clinical Data Is Not Required for ...  Mar 17, 2006
...to support the approval of Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for SEASONIQUE(TM) (levonorgestrel/ethinyl estradiol tablets 0.15 mg/0.03 ... - PR Newswire



Wyeth Reports Earnings Results for the 2005 Fourth Quarter and ...  Jan 31, 2006
In May, Wyeth submitted an application for LYBREL(TM) (levonorgestrel/ethinyl estradiol), a new oral contraceptive with a unique dosing regimen; in December ... - MSN Money

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional